Silencing of Hepatic Fatty Acid Transporter Protein 5 in Vivo Reverses Diet-induced Non-alcoholic Fatty Liver Disease and Improves Hyperglycemia
Open Access
- 1 August 2008
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (32), 22186-22192
- https://doi.org/10.1074/jbc.m803510200
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Inhibition of protein kinase Cε prevents hepatic insulin resistance in nonalcoholic fatty liver diseaseJournal of Clinical Investigation, 2007
- Liver-Specific Inhibition of ChREBP Improves Hepatic Steatosis and Insulin Resistance in ob/ob MiceDiabetes, 2006
- Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathwaysNature, 2006
- FATP1 Is an Insulin-Sensitive Fatty Acid Transporter Involved in Diet-Induced ObesityMolecular and Cellular Biology, 2006
- Unrestricted Hepatocyte Transduction with Adeno-Associated Virus Serotype 8 Vectors in MiceJournal of Virology, 2005
- Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of EthnicityHepatology, 2004
- Mechanism of Hepatic Insulin Resistance in Non-alcoholic Fatty Liver DiseaseJournal of Biological Chemistry, 2004
- An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivoNature Genetics, 2003
- Fatty acid transport proteins: a current view of a growing familyTrends in Endocrinology & Metabolism, 2001
- Mechanism of hepatic fatty acid uptakeJournal of Hepatology, 1989